Co-expression of these markers correlated significantly with a worse outcome independently of the tumor size, grade, nodal status, and HER2/neu and receptor status, while the ALDH-1 alone did not significantly predict an outcome [60]. This evidence concerns the gene ALDH1A1 and neoplasm.